EnWave Signs Purchase Agreement with The Green Organic Dutchman for Three 120 kW REVtm Machines to Dry Cannabis in Canada

VANCOUVER, British Columbia, March 26, 2019 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) ("EnWave", or the "Company") reported today that it has signed an equipment purchase agreement with The Green Organic Dutchman Holdings Ltd. ("TGOD") to provide TGOD with three additional large-scale 120 kW Radiant Energy Vacuum ("REVtm") machines equipped with Optional Support Equipment and Robotic Arms (the "Agreement"). TGOD has purchased the additional three REVtm processing lines to expand its drying capacity of premium, certified organic cannabis in Canada. The addition of three 120kW REVtm machines will increase its total royalty-bearing cannabis processing capacity to a combined total of 420kW of REVtm machinery. The Company previously announced on January 3, 2019 that EnWave, TGOD and Tilray, Inc. had entered into a sublicense agreement in Canada granting TGOD non-exclusive rights to use EnWave's technology for processing cannabis.

The Agreement further validates the benefits of REVtm technology as a turnkey solution for rapidly drying cannabis and hemp at low-temperatures to provide a high-quality cannabis product. The Agreement also further expands the use of EnWave's REVtm technology within the rapidly growing global medicinal and recreational cannabis market. EnWave's strategy is to commercialize its proprietary REVtm technology throughout the global cannabis sector under its licensing and royalty business model.

About The Green Organic Dutchman

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD's products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

About EnWave

EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum ("REVtm") ? an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REVtm technology, shortening the time from harvest to marketable cannabis products. 

REVtm technology's commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors including legal cannabis. EnWave's strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REVtm technology. The company has signed over twenty royalty-bearing licenses to date, opening up nine distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Corporation, NutraDried Food Company, LLC, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese^® brand. 

EnWave has introduced REVtm as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REVtm platforms:

1. nutraREV^® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
   
   
2. powderREV^® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
   
   
3. quantaREV^® which is used for continuous, high-volume low-temperature drying.

An additional platform, freezeREV^®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Mr. Brent Charleton, CFA
President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: [email protected]

John P.A. Budreski, Executive Chairman at +1 (416) 930-0914
E-mail: [email protected]  

Deborah Honig, Corporate Development at +1 (647) 203-8793
E-mail: [email protected]

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.